Case 8: Initiation of Urate-Lowering Therapy for Standard Advanced Gout

American Journal of Medicine

Volumn 119, Issue 11 SUPPL. 1, 2006, Pages

  Finley, J Michael ^a  

^a Western University of Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ATORVASTATIN; CAPTOPRIL; COLCHICINE; URATE; URICOSURIC AGENT;

ADULT; ARTICLE; CASE REPORT; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; GOUT; HUMAN; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ARTHRITIS, GOUTY; HUMANS; MALE; MIDDLE AGED; OXYPURINOL; THIAZOLES; URIC ACID; URICOSURIC AGENTS;

EID: 33750087291     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.06.023     Document Type: Article

References (9)

1. Weiner G.I., White S.R., Weitzner R.I., and Rubinstein H.M. Double-blind study of fenoprofen versus phenylbutazone in acute gouty arthritis. Arthritis Rheum 22 (1979) 425-426
2. Fam A.G. Gout, diet, and the insulin resistance syndrome. J Rheumatol 29 (2002) 1350-1355
3. Shahinfar S., Simpson R.L., Carides A.D., et al. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia [published correction appears in Kidney Int.2000;57:370]. Kidney Int 56 (1999) 1879-1885
4. Perez-Ruiz F., Alonso-Ruiz A., Calabozo M., Herrero-Beites A., Garcia-Erauskin G., and Ruiz-Lucea E. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia: a pathogenic approach to the treatment of primary chronic gout. Ann Rheum Dis 57 (1998) 545-549
5. Hande K.R., Noone R.M., and Stone W.J. Severe allopurinol toxicity: description and guidelines for prevention in patients with renal insufficiency. Am J Med 76 (1984) 47-56
6. Becker M.A., Schumacher Jr. H.R., Wortmann R.L., et al. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout. Arthritis Rheum 52 (2005) 916-923
7. Walter-Sack I., deVries J.X., Kutschker C., Ittensohn A., and Voss A. Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals. Eur J Clin Pharmacol 49 (1995) 215-220
8. Abdelrahman M., Rafi A., Ghacha R., Youmbissi J.T., Qayyum T., and Karkar A. Hyperuricemia and gout in renal transplant recipients. Ren Fail 24 (2002) 361-367
9. Fang J., and Alderman M.H. Serum uric acid and cardiovascular mortality: the NHANES [National Health and Nutrition Examination Survey] I epidemiologic follow-up study, 1971-1992. JAMA 283 (2000) 2404-2410